Drugs / ALTB-168
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03298022 | May 2018 → Apr 2020 | ulcerative colitis | AltruBio Inc. | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALTB-168 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03298022 ↗ |